 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV

NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. ( Myovant or the Company ) (NASDAQ: MYOV). Such investors are...

The deal was announced on 23 October 2022. Sumitovant has acquired all outstanding shares of Myovant it did not own through the all-cash deal. Following the completion of
The post Sumitovant Biopharma completes acquisition of Myovant Sciences appeared first on Pharmaceutical Business review...

Sumitovant Biopharma completes acquisition of Myovant Sciences

StockNews.com started coverage on shares of Myovant Sciences (NYSE:MYOV Get Rating) in a report issued on Friday. The brokerage issued a hold rating on the stock. Myovant Sciences Stock Down 0.0 % MYOV opened at $26.98 on Friday. Myovant Sciences has a 52-week low of $7.67 and a 52-week high of $27....

StockNews.com Initiates Coverage on Myovant Sciences (NYSE:MYOV)

This is a Bullish indicator signaling MYOV's price could rise from here. Traders may explore going long the stock or buying call options...

Myovant Sciences (MYOV, $26.99) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 8, 2023

This is a Bearish indicator signaling MYOV's price could decline from here. Traders may explore shorting the stock or put options...

Myovant Sciences (MYOV, $26.95) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 2, 2023

This price move could be a signal that MYOV may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Myovant Sciences (MYOV, $26.97) price may drop as it broke higher Bollinger Band on Feb 17, 2023

Myovant Sciences (MYOV, $26.95) price may drop as it broke higher Bollinger Band on Feb 15, 2023

Tower Research Capital LLC TRC boosted its holdings in Myovant Sciences Ltd. (NYSE:MYOV Get Rating) by 1,840.4% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 125,544 shares of the companys stock after buying an additional 119,074 shares ...

Tower Research Capital LLC TRC Purchases 119,074 Shares of Myovant Sciences Ltd. (NYSE:MYOV)

Myovant Sciences (MYOV, $26.93) price may drop as it broke higher Bollinger Band on Feb 13, 2023

Myovant Sciences is a biotech company that develops new treatments for infertility in women and prostate cancer in men. The company's product capabilities and help continue to deliver innovative therapies addressing unmet patient needs in prostate cancer and women’s health. Myovant Sciences was established in 2016 and is based in Brisbane, California.

Watchers	6,984
52-Wk Low	$7.67
52-Wk High	$27.06

Market Cap	$2.62B
Volume (M)	73,478.00
52-Wk High	$27.06
52-Wk Low	$7.67

MYOV Myovant Sciences Ltd

About

Feed

News

Fundamentals